Antidiabetic activity of Sedum dendroideum: Metabolic enzymes as putative targets for the bioactive flavonoid kaempferitrin

IUBMB Life

Volumn 66, Issue 5, 2014, Pages 361-370

  Da Silva, Daniel ^a   Casanova, Livia Marques ^a   Marcondes, Mariah Celestino ^a   Espindola Netto, Jair MacHado ^a   Paixão, Larissa Pereira ^a   De Melo, Giany Oliveira ^a,b   Zancan, Patricia ^a   Sola Penna, Mauro ^a   Costa, Sônia Soares ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional da Propriedade Industrial (INPI)   (Brazil)

Author keywords

diabetes; flavonoids; kaempferitrin; PFK; Sedum dendroideum

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ANTIDIABETIC AGENT; ASTRAGALIN; FLAVONOID; KAEMPFEROL 3 NEOHESPERIDOSIDE 7 RHAMNOSIDE; KAEMPFEROL 3 RHAMNOSIDE; KAEMPFEROL 3,7 DIRHAMNOSIDE; LACTIC ACID; PLANT EXTRACT; SEDUM DENDROIDEUM EXTRACT; UNCLASSIFIED DRUG; KAEMPFEROL DERIVATIVE; LESPENEFRIL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CRASSULACEAE; GLUCOSE INTAKE; GLUCOSE UTILIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; MALE; MOUSE; NONHUMAN; SEDUM DENDROIDEUM; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION; ANIMAL; CARBOHYDRATE METABOLISM; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; INTRAABDOMINAL FAT; ISOLATION AND PURIFICATION; METABOLISM; MYOBLAST;

ANIMALS; CARBOHYDRATE METABOLISM; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; HYPOGLYCEMIC AGENTS; INTRA-ABDOMINAL FAT; KAEMPFEROLS; LIVER; MALE; MICE; MUSCLE, SKELETAL; MYOBLASTS; PHOSPHOFRUCTOKINASES; PLANT EXTRACTS; SEDUM;

EID: 84902489922     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1270     Document Type: Article

References (53)

1. Home, P., (2003) The challenge of poorly controlled diabetes mellitus. Diabetes Metab. 29, 101-109.
2. World Health Organization (2011) Global Status Report on Noncommunicable Diseases 2010. p. 176, World Health Organization, Geneva, Switzerland.
3. Hays, N. P., Galassetti, P. R., and, Coker, R. H., (2008) Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol. Ther. 118, 181-191.
4. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33, S62-S69.
5. Dey, L., Attele, A. S., and, Yuan, C. S., (2002) Alternative therapies for type 2 diabetes. Altern. Med. Rev. 7, 45-58.
6. Stolar, M. W., (2010) Defining and achieving treatment success in patients with type 2 diabetes mellitus. Mayo Clin. Proc. 85, 24.
7. Qi, L. W., Liu, E. H., Chu, C., Peng, Y. B., Cai, H. X., et al. (2010) Anti-diabetic agents from natural products-an update from 2004 to 2009. Curr. Top. Med. Chem. 10, 434-457.
8. Fabricant, D. S., and, Farnsworth, N. R., (2001) The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 1, 69-75.
9. Ivorra, M. D., Paya, M., and, Villar, A., (1989) A review of natural products and plants as potential antidiabetic drugs. J. Ethnopharmacol. 27, 243-275.
10. Marles, R. J., and, Farnsworth, N. R., (1995) Antidiabetic plants and their active constituents. Phytomedicine 2, 137-189.
11. Mukherjee, P. K., Maiti, K., Mukherjee, K., and, Houghton, P. J., (2006) Leads from Indian medicinal plants with hypoglycemic potentials. J. Ethnopharmacol. 106, 1-28.
12. Silva, F. R., Szpoganicz, B., Pizzolatti, M. G., Willrich, M. A., and, de Sousa, E., (2002) Acute effect of Bauhinia forficata on serum glucose levels in normal and alloxan-induced diabetic rats. J. Ethnopharmacol. 83, 33-37.
13. Fuentes, O., Arancibia-Avila, P., and, Alarcon, J., (2004) Hypoglycemic activity of Bauhinia candicans in diabetic induced rabbits. Fitoterapia 75, 527-532.
14. Menezes, F. D. S., Minto, A. B. M., Ruela, H. S., Kuster, R. M., Sheridan, H., et al. (2007) Hypoglycemic activity of two Brazilian Bauhinia species: Bauhinia forficata L. and Bauhinia monandra Kurz. Rev. Bras. Farmacognosia 17, 8-13.
15. Almeida, E. R., Guedes, M. C., Albuquerque, J. F., and, Xavier, H., (2006) Hypoglycemic effect of Bauhinia cheilandra in rats. Fitoterapia 77, 276-278.
16. Lino Cde, S., Diogenes, J. P., Pereira, B. A., Faria, R. A., Andrade Neto, M., et al. (2004) Antidiabetic activity of Bauhinia forficata extracts in alloxan-diabetic rats. Biol. Pharm. Bull. 27, 125-127.
17. de Sousa, E., Zanatta, L., Seifriz, I., Creczynski-Pasa, T. B., Pizzolatti, M. G., et al. (2004) Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(α)-dirhamnoside from Bauhinia forficata leaves. J. Nat. Prod. 67, 829-832.
18. Jorge, A. P., Horst, H., de Sousa, E., Pizzolatti, M. G., and, Silva, F. R., (2004) Insulinomimetic effects of kaempferitrin on glycaemia and on 14C-glucose uptake in rat soleus muscle. Chem. Biol. Interact. 149, 89-96.
19. De Melo, G. O., Malvar Ddo, C., Vanderlinde, F. A., Pires, P. A., Cortes, W. S., et al. (2005) Phytochemical and pharmacological study of Sedum dendroideum leaf juice. J. Ethnopharmacol. 102, 217-220.
20. De Melo, G. O., Malvar Ddo, C., Vanderlinde, F. A., Rocha, F. F., Pires, P. A., et al. (2009) Antinociceptive and anti-inflammatory kaempferol glycosides from Sedum dendroideum. J. Ethnopharmacol. 124, 228-232.
21. Melendez Camargo, M. E., Buendia Romero, M., Ramos Zamora, D., Cardona Carrillo, P., and, Villarreal Maldonado, M. E., (2002) Study of the anti-inflammatory effect of Sedum praealtum (Siempreviva) in the rat: dose-dependent response. Proc. West. Pharmacol. Soc. 45, 129-130.
22. Andrade-Cetto, A., and, Heinrich, M., (2005) Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J. Ethnopharmacol. 99, 325-348.
23. Da Silva, D., Zancan, P., Coelho, W. S., Gomez, L. S., and, Sola-Penna, M., (2010) Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse. Arch. Biochem. Biophys. 496, 53-60.
24. Sola-Penna, M., dos Santos, A. C., Alves, G. G., El-Bacha, T., Faber-Barata, J., et al. (2002) A radioassay for phosphofructokinase-1 activity in cell extracts and purified enzyme. J. Biochem. Biophys. Methods 50, 129-140.
25. Zancan, P., and, Sola-Penna, M., (2005) Regulation of human erythrocyte metabolism by insulin: cellular distribution of 6-phosphofructo-1-kinase and its implication for red blood cell function. Mol. Genet. Metab. 86, 401-411.
26. Zancan, P., and, Sola-Penna, M., (2005) Calcium influx: a possible role for insulin modulation of intracellular distribution and activity of 6-phosphofructo-1-kinase in human erythrocytes. Mol. Genet. Metab. 86, 392-400.
27. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and, Randall, R. J., (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
28. Furtado, C. M., Marcondes, M. C., Sola-Penna, M., de Souza, M. L. S., and, Zancan, P., (2012) Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis. PLoS One 7, e30462.
29. Gomez, L. S., Zancan, P., Marcondes, M. C., Ramos-Santos, L., Meyer-Fernandes, J. R., et al. (2013) Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie 95, 1336-1343.
30. Sola-Penna, M., Da Silva, D., Coelho, W. S., Marinho-Carvalho, M. M., and, Zancan, P., (2010) Regulation of mammalian muscle type 6-phosphofructo-1- kinase and its implication for the control of the metabolism. IUBMB Life 62, 791-796.
31. Real-Hohn, A., Zancan, P., Da Silva, D., Martins, E. R., Salgado, L. T., et al. (2010) Filamentous actin and its associated binding proteins are the stimulatory site for 6-phosphofructo-1-kinase association within the membrane of human erythrocytes. Biochimie 92, 538-544.
32. Das, B., Tandon, V., and, Saha, N., (2004) Anthelmintic efficacy of Flemingia vestita (Fabaceae): alteration in the activities of some glycolytic enzymes in the cestode, Raillietina echinobothrida. Parasitol. Res. 93, 253-261.
33. Oddis, C. V., and, Finkel, M. S., (1995) Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem. Biophys. Res. Commun. 213, 1002-1009.
34. Spitz, G. A., Furtado, C. M., Sola-Penna, M., and, Zancan, P., (2009) Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem. Pharmacol. 77, 46-53.
35. Cazarolli, L. H., Pereira, D. F., Kappel, V. D., Folador, P., Figueiredo Mdos, S., et al. (2013) Insulin signaling: a potential signaling pathway for the stimulatory effect of kaempferitrin on glucose uptake in skeletal muscle. Eur. J. Pharmacol. 712, 1-7.
36. Tzeng, Y.-M., Chen, K., Rao, Y. K., and, Lee, M.-J., (2009) Kaempferitrin activates the insulin signaling pathway and stimulates secretion of adiponectin in 3T3-L1 adipocytes. Eur. J. Pharmacol. 607, 27-34.
37. Hollman, P. C. H., (2004) Absorption, bioavailability, and metabolism of flavonoids. Pharm. Biol. 42, 74-83.
38. Estrada, O., Hasegawa, M., Gonzalez-Mujica, F., Motta, N., Perdomo, E., et al. (2005) Evaluation of flavonoids from Bauhinia megalandra leaves as inhibitors of glucose-6-phosphatase system. Phytother. Res. 19, 859-863.
39. Tadera, K., Minami, Y., Takamatsu, K., and, Matsuoka, T., (2006) Inhibition of α-glucosidase and α-amylase by flavonoids. J. Nutr. Sci. Vitaminol. 52, 149-153.
40. Kato, A., Nasu, N., Takebayashi, K., Adachi, I., Minami, Y., et al. (2008) Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase. J. Agric. Food Chem. 56, 4469-4473.
41. Wootten, D., Simms, J., Koole, C., Woodman, O. L., Summers, R. J., et al. (2011) Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. J. Pharmacol. Exp. Ther. 336, 540-550.
42. Azuma, T., Kayano, S.-I., Matsumura, Y., Konishi, Y., Tanaka, Y., et al. (2011) Antimutagenic and α-glucosidase inhibitory effects of constituents from Kaempferia parviflora. Food Chem. 125, 471-475.
43. Nicolle, E., Souard, F., Faure, P., and, Boumendjel, A., (2011) Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship. Curr. Med. Chem. 18, 2661-2672.
44. Huang, S., and, Czech, M. P., (2007) The GLUT4 glucose transporter. Cell Metab. 5, 237-252.
45. Ferrarezi, D. A., Cheurfa, N., Reis, A. F., Fumeron, F., and, Velho, G., (2007) Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences. Arq. Bras. Endocrinol. Metab. 51, 153-159.
46. Tajiri, Y., Umeda, F., Inoguchi, T., and, Nawata, H., (1994) Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat. J. Diabetes Complications 8, 126-132.
47. Guerreiro, L. H., Da Silva, D., Sola-Penna, M., Mizurini, D. M., and, Lima, L. M. T. R., (2013) Amylin induces hypoglycemia in mice. An. Acad. Bras. Cienc. 85, 349-354.
48. Da Silva, D., Ausina, P., Alencar, E. M., Coelho, W. S., Zancan, P., et al. (2012) Metformin reverses hexokinase and phosphofructokinase downregulation and intracellular distribution in the heart of diabetic mice. IUBMB Life 64, 766-774.
49. Stanley Mainzen Prince, P., and, Kamalakkannan, N., (2006) Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J. Biochem. Mol. Toxicol. 20, 96-102.
50. Babujanarthanam, R., Kavitha, P., and, Pandian, M. R., (2010) Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin-induced diabetic tissues by altering glycolytic and gluconeogenic enzymes. Fundam. Clin. Pharmacol. 24, 357-364.
51. Prasath, G. S., and, Subramanian, S. P., (2011) Modulatory effects of fisetin, a bioflavonoid, on hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in hepatic and renal tissues in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 668, 492-496.
52. Jung, U. J., Lee, M. K., Jeong, K. S., and, Choi, M. S., (2004) The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 134, 2499-2503.
53. Pari, L., and, Srinivasan, S., (2010) Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin- nicotinamide-induced diabetic rats. Biomed. Pharmacother. 64, 477-481. Nível Superior